Drug Name | Fabrazyme®(agalsidase beta) |
---|---|
Drug Class | |
Risk minimization type |
Other
|
Specialty (Theraputic area) | |
Risk |
guidance to HCP and patients for the management of patient receiving Fabrazyme |
other |
Home Infusion HCP Manual Home Infusion Patient Manual Home Infusion Patient Manual Arabic |